Skip to main content

Research News

  • The cost of treating Hepatitis C virus (HCV) could be reduced by half if doctors are trained to predict when a patient can safely stop taking the expensive but effective direct-acting antiviral (DAA) medication, suggests new research.

  • Researchers, including one of Indian-origin, have created a new molecule for prostate cancer that has shown great efficacy when tested in mice.The findings suggest that the new therapeutic might be a viable treatment for prostate cancer in humans too if it is found effective the future clinical trials.

  • Using antibiotics as the primary treatment for appendicitis does not increase the risk for complications at least in the first year and can significantly reduce the number of surgeries by 92 percent within the first month of diagnosis, finds a new study.

  • A team of British researchers has discovered how the immune system stops bacteria in our gut from leaking into the blood stream that may help in treatment and prevention of life threatening infections.

  • Scientists have developed a pill that could significantly improve the imaging techniques involved in breast cancer and can better help in the diagnosis of the deadly disease  the second most common cancer in women.

    [adsense:336x280:8701650588]

  • A weak ecosystem of bacteria in human gut due to a poor dietary diversity is likely to trigger diseases like Type 2 diabetes and obesity, finds new research, suggesting people to eat a balanced, diversed diet.

  • Using stem cells derived from human skin cells, US researchers have revealed that these can be turned into retinal ganglion cells (RGCs) the neurons that conduct visual information from the eye to the brain to prevent or cure glaucoma.

Subscribe to Research News